Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature

Clostridium difficile colitis, although rare, could represent a serious complication following chemotherapy. Prior antibiotic use has been considered the single most important risk factor in the development of C. difficile infection. Recently, the association between antineoplastic therapy and C. di...

Full description

Saved in:
Bibliographic Details
Main Authors: V. Masciullo, S. Mainenti, D. Lorusso, P. A. Margariti, G. Scambia
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Obstetrics and Gynecology International
Online Access:http://dx.doi.org/10.1155/2010/749789
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561636341186560
author V. Masciullo
S. Mainenti
D. Lorusso
P. A. Margariti
G. Scambia
author_facet V. Masciullo
S. Mainenti
D. Lorusso
P. A. Margariti
G. Scambia
author_sort V. Masciullo
collection DOAJ
description Clostridium difficile colitis, although rare, could represent a serious complication following chemotherapy. Prior antibiotic use has been considered the single most important risk factor in the development of C. difficile infection. Recently, the association between antineoplastic therapy and C. difficile-associated diarrhea in the absence of a prior antibiotic therapy has become more apparent. A 75-year-old woman with serous adenocarcinoma of the ovary developed lethal pancolitis caused by C. difficile after five cycles of paclitaxel- and carboplatin-based chemotherapy. She presented with diarrhea, coffee-ground emesis, and oliguria and was hospitalized immediately for aggressive treatment. Despite all the medical efforts, her condition worsened and she died after twenty days. We describe the second case reported of a patient developing a severe C. difficile colitis following chemotherapy without any recent antibiotic use and review the data of the literature, emphasizing the need to a prompt diagnosis and management that can significantly decrease the morbidity and life-threatening complications associated with this infection.
format Article
id doaj-art-5357487a3ec1460eade94579d103c324
institution Kabale University
issn 1687-9589
1687-9597
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Obstetrics and Gynecology International
spelling doaj-art-5357487a3ec1460eade94579d103c3242025-02-03T01:24:31ZengWileyObstetrics and Gynecology International1687-95891687-95972010-01-01201010.1155/2010/749789749789Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the LiteratureV. Masciullo0S. Mainenti1D. Lorusso2P. A. Margariti3G. Scambia4Division of Gynecologic Oncology, Catholic University of Sacred Heart, L. go A. Gemelli, 8, 00168 Rome, ItalyDivision of Gynecologic Oncology, Catholic University of Sacred Heart, L. go A. Gemelli, 8, 00168 Rome, ItalyDivision of Gynecologic Oncology, Catholic University of Sacred Heart, L. go A. Gemelli, 8, 00168 Rome, ItalyDivision of Gynecologic Oncology, Catholic University of Sacred Heart, L. go A. Gemelli, 8, 00168 Rome, ItalyDivision of Gynecologic Oncology, Catholic University of Sacred Heart, L. go A. Gemelli, 8, 00168 Rome, ItalyClostridium difficile colitis, although rare, could represent a serious complication following chemotherapy. Prior antibiotic use has been considered the single most important risk factor in the development of C. difficile infection. Recently, the association between antineoplastic therapy and C. difficile-associated diarrhea in the absence of a prior antibiotic therapy has become more apparent. A 75-year-old woman with serous adenocarcinoma of the ovary developed lethal pancolitis caused by C. difficile after five cycles of paclitaxel- and carboplatin-based chemotherapy. She presented with diarrhea, coffee-ground emesis, and oliguria and was hospitalized immediately for aggressive treatment. Despite all the medical efforts, her condition worsened and she died after twenty days. We describe the second case reported of a patient developing a severe C. difficile colitis following chemotherapy without any recent antibiotic use and review the data of the literature, emphasizing the need to a prompt diagnosis and management that can significantly decrease the morbidity and life-threatening complications associated with this infection.http://dx.doi.org/10.1155/2010/749789
spellingShingle V. Masciullo
S. Mainenti
D. Lorusso
P. A. Margariti
G. Scambia
Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature
Obstetrics and Gynecology International
title Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature
title_full Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature
title_fullStr Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature
title_full_unstemmed Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature
title_short Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature
title_sort lethal clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy in ovarian carcinoma case report and review of the literature
url http://dx.doi.org/10.1155/2010/749789
work_keys_str_mv AT vmasciullo lethalclostridiumdifficilecolitisassociatedwithpaclitaxelandcarboplatinchemotherapyinovariancarcinomacasereportandreviewoftheliterature
AT smainenti lethalclostridiumdifficilecolitisassociatedwithpaclitaxelandcarboplatinchemotherapyinovariancarcinomacasereportandreviewoftheliterature
AT dlorusso lethalclostridiumdifficilecolitisassociatedwithpaclitaxelandcarboplatinchemotherapyinovariancarcinomacasereportandreviewoftheliterature
AT pamargariti lethalclostridiumdifficilecolitisassociatedwithpaclitaxelandcarboplatinchemotherapyinovariancarcinomacasereportandreviewoftheliterature
AT gscambia lethalclostridiumdifficilecolitisassociatedwithpaclitaxelandcarboplatinchemotherapyinovariancarcinomacasereportandreviewoftheliterature